UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European journal of cancer (1990), ISSN 0959-8049, 2008, Volume 44, Issue 11, pp. 1507 - 1515
Hematology, Oncology and Palliative Medicine | Prevention | Chemotherapy | Neuropathy | Paclitaxel | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Tumors | Peripheral Nervous System Diseases - chemically induced | Magnesium - administration & dosage | Humans | Calcium - administration & dosage | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Paclitaxel - therapeutic use | Randomized Controlled Trials as Topic | Antidepressive Agents, Tricyclic - therapeutic use | Peripheral Nervous System Diseases - prevention & control | Antineoplastic Agents - adverse effects | Vitamin E - therapeutic use | Glutamine - therapeutic use | Ketamine - therapeutic use | Acetylcarnitine - therapeutic use | Acetylcysteine - therapeutic use | Infusions, Intravenous | Naphthalenes - therapeutic use | Baclofen - therapeutic use | Pyridines - therapeutic use | Index Medicus
Journal Article
Medicina (Kaunas, Lithuania), ISSN 1010-660X, 01/2021, Volume 57, Issue 1, p. 58
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Urate Oxidase - therapeutic use | Humans | Propionates - therapeutic use | Evidence-Based Medicine | Polyethylene Glycols - therapeutic use | Thioglycolates - therapeutic use | Hyperuricemia - drug therapy | Gout Suppressants - therapeutic use | Allopurinol - therapeutic use | Benzbromarone - therapeutic use | Acetamides - therapeutic use | Febuxostat - therapeutic use | Phenylacetates - therapeutic use | Chronic Disease | Naphthalenes - therapeutic use | Probenecid - therapeutic use | Xanthine Oxidase - antagonists & inhibitors | Nitriles - therapeutic use | Pyridines - therapeutic use | Triazoles - therapeutic use | Uricosuric Agents - therapeutic use | Index Medicus | uric acid-lowering drugs | hyperuricemia | xanthine oxidase inhibitors | uric acid | uricosurics
Journal Article
Breast (Edinburgh), ISSN 0960-9776, 02/2018, Volume 37, pp. 126 - 133
Selective FGFR inhibitors | FGFR amplification | Multitargeted TKIs | Breast cancer | Fibroblast growth factor receptor (FGFR) | Tyrosine kinase receptor | Tyrosine kinase inhibitors | Oncology | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Pyrazoles - therapeutic use | Humans | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Fibroblast Growth Factors - genetics | Phenylurea Compounds - therapeutic use | Drug Resistance, Neoplasm | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Drug Synergism | Fibroblast Growth Factors - metabolism | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinolones - therapeutic use | Receptors, Fibroblast Growth Factor - metabolism | Receptors, Fibroblast Growth Factor - genetics | Female | Quinolines - therapeutic use | Naphthalenes - therapeutic use | Benzimidazoles - therapeutic use | Quinoxalines - therapeutic use | Tyrosine | Fibroblast growth factors | Metastasis | Index Medicus
Journal Article
Neurotherapeutics, ISSN 1933-7213, 10/2017, Volume 14, Issue 4, pp. 859 - 873
Neurology | Neurosciences | Biomedicine | Neurosurgery | Neurobiology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | Treatment Outcome | Clinical Trials as Topic | Thiazoles - therapeutic use | Indans - therapeutic use | Oxadiazoles - therapeutic use | Propanolamines - therapeutic use | Animals | Azetidines - therapeutic use | Benzyl Compounds - therapeutic use | Indoles - therapeutic use | Receptors, Lysosphingolipid - metabolism | Fingolimod Hydrochloride - therapeutic use | Naphthalenes - therapeutic use | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Multiple Sclerosis - metabolism | Multiple sclerosis | Lymphatic system | Developmental stages | Lymphocytes | Cardiomyocytes | Myocytes | Heart diseases | Lymph nodes | Regulatory approval | Sphingosine 1-phosphate | Index Medicus | Review
Journal Article
American journal of clinical dermatology, ISSN 1175-0561, 2008, Volume 9, Issue 6, pp. 369 - 381
Tretinoin, therapeutic use | Retinaldehyde, therapeutic use | Isotretinoin, therapeutic use | Tazarotene, therapeutic use | Adapalene, therapeutic use | Retinoids, therapeutic use | Acne vulgaris, treatment | Retinol, therapeutic use | Life Sciences & Biomedicine | Dermatology | Science & Technology | Isotretinoin - therapeutic use | Adapalene | Humans | Acne Vulgaris - drug therapy | Retinoids - administration & dosage | Retinoids - therapeutic use | Tretinoin - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Safety | Drug Therapy, Combination | Administration, Topical | Naphthalenes - therapeutic use | Nicotinic Acids - therapeutic use | Index Medicus
Journal Article
Cochrane library, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD007360 - CD007360
Piperazines | Plant Extracts | Benzilates | Adrenergic alpha‐Antagonists | Urology | Alpha‐blockers/Alpha‐1 adrenoceptors/Alpha antagonists/5‐alpha reductase inhibitors | Naphthalenes | Randomized Controlled Trials as Topic | Prostatic Hyperplasia | Urological Agents | Tamsulosin | Lower Urinary Tract Symptoms | Sulfonamides | Quality of Life | Prostatism | Benign prostatic hyperplasia | Treatment of Benign Prostatic Hyperplasia | Ethamsylate | Indoles | Pharmacologic/Medical Therapies | Medicine General & Introductory Medical Sciences | Drug Combinations | Naftopidil | Benign Prostatic Hyperplasia/Obstruction (Hypertrophy, Prostatic Hyperplasia) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Benzilates - adverse effects | Naphthalenes - adverse effects | Benzilates - therapeutic use | Humans | Adrenergic alpha-Antagonists - therapeutic use | Male | Prostatic Hyperplasia - complications | Prostatism - drug therapy | Urological Agents - adverse effects | Adrenergic alpha-Antagonists - adverse effects | Ethamsylate - therapeutic use | Lower Urinary Tract Symptoms - drug therapy | Lower Urinary Tract Symptoms - etiology | Ethamsylate - adverse effects | Urological Agents - therapeutic use | Prostatism - etiology | Tamsulosin - adverse effects | Tamsulosin - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Indoles - adverse effects | Sulfonamides - therapeutic use | Sulfonamides - adverse effects | Indoles - therapeutic use | Plant Extracts - therapeutic use | Naphthalenes - therapeutic use | Plant Extracts - adverse effects | Index Medicus
Journal Article
7.
Full Text
Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack
Behavioural brain research, ISSN 0166-4328, 01/2017, Volume 317, pp. 508 - 514
Panic | Chemoreflex | Cannabinoid | CB1 receptor | Aversion | Benzodiazepines | receptor | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Behavioral Sciences | Science & Technology | Rats, Wistar | Male | Hypnotics and Sedatives - therapeutic use | Dose-Response Relationship, Drug | Heart Rate - drug effects | Benzamides - therapeutic use | Serotonin - therapeutic use | Enzyme Inhibitors - toxicity | Escape Reaction - drug effects | Potassium Cyanide - toxicity | Blood Pressure - drug effects | Morpholines - therapeutic use | Disease Models, Animal | Locomotion - drug effects | Analgesics - therapeutic use | Alprazolam - therapeutic use | Panic Disorder - drug therapy | Benzoxazines - therapeutic use | Panic Disorder - chemically induced | Cannabinoids - therapeutic use | Animals | Arachidonic Acids - therapeutic use | Serotonin - analogs & derivatives | Mice | Carbamates - therapeutic use | Naphthalenes - therapeutic use | Alprazolam | Analysis | Anxiety | Cyanides | Index Medicus
Journal Article
Clinics in dermatology, ISSN 0738-081X, 2010, Volume 28, Issue 2, pp. 151 - 159
Dermatology | Life Sciences & Biomedicine | Science & Technology | Drug Administration Schedule | Onychomycosis - drug therapy | Administration, Oral | Foot Dermatoses - drug therapy | Humans | Ciclopirox | Administration, Cutaneous | Thiazoles - therapeutic use | Fluconazole - therapeutic use | Terbinafine | Antifungal Agents - therapeutic use | Foot Dermatoses - microbiology | Mitosporic Fungi - drug effects | Itraconazole - therapeutic use | Mitosporic Fungi - isolation & purification | Pyrimidines - therapeutic use | Voriconazole | Pyridones - therapeutic use | Drug Therapy, Combination | Onychomycosis - diagnosis | Morpholines - therapeutic use | Naphthalenes - therapeutic use | Triazoles - therapeutic use | Index Medicus
Journal Article